Diffusion limits of an in vitro thick prevascularized tissue.

Although tissue engineering promises to replace or restore lost function to nearly every tissue in the body, successful applications are currently limited to tissue less than 2 mm in thickness. in vivo capillary networks deliver oxygen and nutrients to thicker (> 2 mm) tissues, suggesting that introduction of a preformed in vitro vascular network may be a useful strategy for engineered tissues. This article describes a system for generating capillary-like networks within a thick fibrin matrix. Human umbilical vein endothelial cells, growing on the surface of microcarrier beads, were embedded in fibrin gels a known distance (Delta = 1.8-4.5 mm) from a monolayer of human dermal fibroblasts. The distance of the growth medium, which contained vascular endothelial growth factor and basic fibroblast growth factor, from the beads, C, was varied from 2.7 to 7.2 mm. Capillaries with visible lumens sprouted in 2-3 days, reaching lengths that exceeded 500 microm within 6-8 days. On day 7, capillary network formation was largely independent of C; however, a strong inverse correlation with Delta was observed, with the maximum network formation at Delta = 1.8 mm. Surprisingly, the thickness of the gel was not a limiting factor for oxygen diffusion as these tissue constructs retained a relatively high oxygen tension of > 125 mmHg. We conclude that diffusion of oxygen in vitro is not limiting, allowing the development of tissue constructs on the order of centimeters in thickness. In addition, diffusion of fibroblast-derived soluble mediators is necessary for stable capillary formation, but is significantly impeded relative to that of nutrients present in the medium.

[1]  Hyun Chul Lee,et al.  Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.

[2]  V. Zaric,et al.  [Therapeutic angiogenesis using genetic transfection. An in vitro quantitative and functional study after gene code transfer for vascular endothelial growth factor]. , 2000, Archives des maladies du coeur et des vaisseaux.

[3]  C. Patrick,et al.  Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. , 2000, Journal of biomedical materials research.

[4]  R J Cohen,et al.  Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. , 1999, American journal of physiology. Heart and circulatory physiology.

[5]  W. Bensinger,et al.  Optimization of Peripheral Blood Stem Cell Mobilization , 1996, Stem cells.

[6]  D J Mooney,et al.  Optimizing seeding and culture methods to engineer smooth muscle tissue on biodegradable polymer matrices. , 1998, Biotechnology and bioengineering.

[7]  J L Cleland,et al.  Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[8]  G. Ehninger,et al.  Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors. , 1998, Bone marrow transplantation.

[9]  K. Burg,et al.  In vivo characterization of a porous hydrogel material for use as a tissue bulking agent. , 2001, Journal of biomedical materials research.

[10]  Steven C George,et al.  Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. , 2006, Tissue engineering.

[11]  Y. M. Elçin,et al.  Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. , 2001, Artificial organs.

[12]  E. Dejana,et al.  Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[13]  B. Weinstein,et al.  In vivo imaging of embryonic vascular development using transgenic zebrafish. , 2002, Developmental biology.

[14]  R Langer,et al.  Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. , 2001, American journal of physiology. Heart and circulatory physiology.

[15]  Anthony Atala,et al.  Systems for therapeutic angiogenesis in tissue engineering , 2000, World Journal of Urology.

[16]  Robert Langer,et al.  Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.

[17]  M. Ikekita,et al.  Establishment of heterotropic liver tissue mass with direct link to the host liver following implantation of hepatocytes transfected with vascular endothelial growth factor gene in mice. , 2001, Tissue engineering.

[18]  J. Vacanti,et al.  Human hepatocyte isolation and transplantation into an athymic rat, using prevascularized cell polymer constructs. , 1995, Journal of pediatric surgery.

[19]  B. Frerich,et al.  In vitro model of a vascular stroma for the engineering of vascularized tissues. , 2001, International journal of oral and maxillofacial surgery.

[20]  R. Weisel,et al.  Construction of a bioengineered cardiac graft. , 2000, The Journal of thoracic and cardiovascular surgery.

[21]  David J. Mooney,et al.  Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.

[22]  S J Bryant,et al.  The effects of scaffold thickness on tissue engineered cartilage in photocrosslinked poly(ethylene oxide) hydrogels. , 2001, Biomaterials.

[23]  G. Vunjak‐Novakovic,et al.  Gas exchange is essential for bioreactor cultivation of tissue engineered cartilage. , 1999, Biotechnology and bioengineering.

[24]  C. Zandonella Tissue engineering: The beat goes on , 2003, Nature.

[25]  G Tellides,et al.  In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Vunjak‐Novakovic,et al.  Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. , 1999, Experimental cell research.

[27]  S. George,et al.  A three-dimensional in vitro model of angiogenesis in the airway mucosa. , 2007, Pulmonary pharmacology & therapeutics.

[28]  S. Schmidt,et al.  Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia. , 1998, Journal of vascular surgery.

[29]  B. Stephens The Beat Goes On , 1991, Science.

[30]  M. Pepper,et al.  Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. , 1997, Cytokine & growth factor reviews.

[31]  David J Mooney,et al.  Engineering vascular networks in porous polymer matrices. , 2002, Journal of biomedical materials research.

[32]  C. Patrick,et al.  Preadipocyte seeded PLGA scaffolds for adipose tissue engineering. , 1999, Tissue engineering.

[33]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.

[34]  Y Ikada,et al.  Controlled release of vascular endothelial growth factor by use of collagen hydrogels , 2000, Journal of biomaterials science. Polymer edition.